ClearPoint Neuro (CLPT) Share-based Compensation (2011 - 2026)
ClearPoint Neuro (CLPT) posted Share-based Compensation of $2.0 million for Q1 2026, up 0.61% sequentially from $2.0 million in Q4 2025, and up 4.45% YoY from $1.9 million in Q1 2025.
ClearPoint Neuro (CLPT) Share-based Compensation (2011 - 2026) Analysis & Trends
ClearPoint Neuro has reported Share-based Compensation for 15 years, with the latest figure at $2.0 million in Q1 2026.
- Quarterly Share-based Compensation rose 4.45% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.2 million (up 1008.94% YoY) and the FY2025 annual result came in at $8.5 million, up 1899.76% from the prior year.
- Share-based Compensation grew to $2.0 million in Q1 2026 per CLPT's latest filing, from $2.0 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $10.3 million in Q3 2025 and troughed at -$4.8 million in Q4 2024.
- A 5-year average of $2.0 million and a median of $1.8 million in 2024 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 29980.0% in 2024, down 409.79% in 2024.
- Over 5 years, Share-based Compensation stood at $3.8 million in 2022, then slumped by 59.29% to $1.5 million in 2023, then sank by 409.79% to -$4.8 million in 2024, then soared by 141.44% to $2.0 million in 2025, then gained by 0.61% to $2.0 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $2.0 million, $2.0 million, and $10.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 12.80 Mn |
| 10 | ClearPoint Neuro | 468.94 Mn | 439.54 Mn | 6.71 Mn | 2.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.27 Mn |
| Jun 30, 2026 | 2.27 Mn |
| Mar 31, 2026 | 1.99 Mn |
| Mar 31, 2026 | 1.99 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Sep 30, 2025 | 10.34 Mn |
| Sep 30, 2025 | 10.34 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | -4.78 Mn |
| Dec 31, 2024 | -4.78 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.50 Mn |